Aulos Bioscience, Inc.
Overview
Aulos Bioscience, Inc. is a biotechnology company focused on developing innovative immuno-oncology treatments. Utilizing proprietary approaches, Aulos aims to provide novel therapies for cancer patients. The company leverages advanced research in cytokine biology to create solutions that empower the immune system to fight cancer.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Aulos Bioscience, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Adventris Pharmaceuticals
United States
Alpha Oncology Therapeutics, Inc.
USA
Cancer Research Innovations, Inc.
USA
Checkpoint Therapeutics, Inc.
United States
Eureka Therapeutics, Inc.
United States
Fate Therapeutics, Inc.
United States
Fred Hutchinson Cancer Center
United States
Global Oncology Research Group
USA
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.